Pharmaceutical company Catalent will expand its Winchester production site and adding 277 jobs to its present 650 employees.
The Somerset-based firm will invest $175 million to expand its Kentucky-based factory, which is set to open in January 2024.
The project includes two additional buildings that will add 107,000 square feet to the manufacturing footprint at the site.
Aris Gennadios, President of Softgel & Oral Technologies at Catalent, said: “The nature of the development pipeline being strong in both oncology treatments and complex molecules necessitate expansion of specific capabilities.”
The development will create more laboratory space, strengthen the facility’s material handling abilities and containment vault, and add capacity for turnkey operations.
Catalent already expanded by 190,000 square feet in 2015 and invested $40 million in new production equipment in 2019.
They have increased fluid bed capacity, stick pack dose, roller compaction, and integrated packaging lines as part of that progress.
Since its inception in 1992, the Winchester facility has produced over 3 billion capsules and tablets and introduced over 150 new products.
Catalent is a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products.